Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers

被引：0
作者：
Mattsson, Niklas [1 ]
Andreasson, Ulf [1 ]
Carrillo, Maria C. [2 ]
Persson, Staffan [1 ]
Shaw, Leslie M. [3 ]
Zegers, Ingrid [4 ]
Zetterberg, Henrik [1 ,5 ]
Blennow, Kaj [1 ]
机构：
[1] Univ Gothenburg, Sahlgrens Univ Hosp, Sahlgrenska Acad,Clin Neurochem Lab, Dept Psychiat & Neurochem,Inst Neurosci & Psychia, Molndal, Sweden
[2] Alzheimers Assoc, Dept Med & Sci Relat, Chicago, IL USA
[3] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[4] European Commiss, Joint Res Ctr, Inst Reference Mat & Measurements, Geel, Belgium
[5] UCL Inst Neurol, London, England
来源：
BIOMARKERS IN MEDICINE | 2012年 / 6卷 / 04期
关键词：
Alzheimer's disease; biomarkers; cerebrospinal fluid; proficiency testing; NEUROCHEMICAL DEMENTIA DIAGNOSTICS; MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; NATIONAL INSTITUTE; XMAP TECHNOLOGY; TAU-PROTEINS; RECOMMENDATIONS; PERFORMANCE; GUIDELINES;
D O I：
10.2217/BMM.12.41
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Cerebrospinal fluid (CSF) biomarkers are increasingly used for diagnosis of Alzheimer's disease in research, clinical trials and clinical settings. As for other biochemical measurements, variability between laboratories for these biomarkers may be monitored by proficiency testing programs, where participating laboratories use their local routine methods to analyze test samples shipped from a central laboratory. In this review, we summarize the results from the last years' pilot proficiency programs and describe the ongoing standardization efforts in this area. Global proficiency testing for CSF biomarkers is now fully established. It will continue to play an important part in the standardization of measurements that is a prerequisite for the broad-scale future implementation of CSF biomarkers.
引用
收藏
页码：401 / 407
页数：7
相关论文
共 50 条
[31]   Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease [J].
Leuzy, Antoine ;
Cullen, Nicholas C. ;
Mattsson-Carlgren, Niklas ;
Hansson, Oskar .
CURRENT OPINION IN NEUROLOGY, 2021, 34 (02) :266-274
[32]   Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease [J].
Mila-Aloma, Marta ;
Suarez-Calvet, Marc ;
Luis Molinuevo, Jose .
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2019, 12
[33]   Cerebrospinal fluid and blood biomarkers in the diagnostic assays of Alzheimer's disease [J].
Zhang, Liding ;
Liang, Xiaohan ;
Zhang, Zhihong ;
Luo, Haiming .
JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES, 2022, 15 (01)
[34]   Association of MAPT haplotype-tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort [J].
Leko, Mirjana Babic ;
Willumsen, Nanet ;
Perkovic, Matea Nikolac ;
Klepac, Natasa ;
Borovecki, Fran ;
Hof, Patrick R. ;
Sonicki, Zdenko ;
Pivac, Nela ;
de Silva, Rohan ;
Simic, Goran .
BRAIN AND BEHAVIOR, 2018, 8 (11)
[35]   Relationship Between β-Secretase, Inflammation and Core Cerebrospinal Fluid Biomarkers for Alzheimer's Disease [J].
Alcolea, Daniel ;
Carmona-Iragui, Maria ;
Suarez-Calvet, Marc ;
Belen Sanchez-Saudinos, M. ;
Sala, Isabel ;
Anton-Aguirre, Sofia ;
Blesa, Rafael ;
Clarimon, Jordi ;
Fortea, Juan ;
Lleo, Alberto .
JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (01) :157-167
[36]   White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers [J].
van Doorn, Linda J. C. van Waalwijk ;
Ghafoorian, Mohsen ;
van Leijsen, Esther M. C. ;
Claassen, Jurgen A. H. R. ;
Arighi, Andrea ;
Bozzali, Marco ;
Cannas, Jorge ;
Cavedo, Enrica ;
Eusebi, Paolo ;
Farotti, Lucia ;
Fenoglio, Chiara ;
Fortea, Juan ;
Frisoni, Giovanni B. ;
Galimberti, Daniela ;
Greco, Viviana ;
Herukka, Sanna-Kaisa ;
Liu, Yawu ;
Lleo, Alberto ;
de Mendonca, Alexandre ;
Nobili, Flavio M. ;
Parnetti, Lucilla ;
Picco, Agnese ;
Pikkarainen, Maria ;
Salvadori, Nicola ;
Scarpini, Elio ;
Soininen, Hilkka ;
Tarducci, Roberto ;
Urbani, Andrea ;
Vilaplana, Eduard ;
Meulenbroek, Olga ;
Platel, Bram ;
Verbeek, Marcel M. ;
Kuiperij, H. Bea .
JOURNAL OF ALZHEIMERS DISEASE, 2021, 79 (01) :163-175
[37]   Cerebrospinal fluid levels of YKL-40 in prodromal Alzheimer's disease [J].
Wang, Lijun ;
Gao, Tianhao ;
Cai, Tengteng ;
Li, Kunyi ;
Zheng, Ping ;
Liu, Jun .
NEUROSCIENCE LETTERS, 2020, 715
[38]   Cerebrospinal fluid biomarkers of Alzheimer’s disease [J].
Xiaojing Sui ;
Jianjun Liu ;
Xifei Yang .
Neuroscience Bulletin, 2014, 30 :233-242
[39]   Cerebrospinal fluid biomarkers of Alzheimer's disease [J].
Xiaojing Sui ;
Jianjun Liu ;
Xifei Yang .
Neuroscience Bulletin, 2014, 30 (02) :233-242
[40]   From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease [J].
Zetterberg, Henrik ;
Blennow, Kaj .
JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 :S271-S279
12345